Brief: Argenica Therapeutics Says Food And Drug Administration Has Granted Orphan Drug Designation Status To ARG-007
15/11/2023 24:50
Nov 15 (Reuters) - Argenica Therapeutics Ltd AGN.AX :
* FOOD AND DRUG ADMINISTRATION HAS GRANTED ORPHAN DRUG
DESIGNATION
STATUS TO ARG-007
Source text for Eikon: ID:nASX6nmCGC
Further company coverage: AGN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M